Deze nieuwsbrief presenteert u de meest gelezen lezingen:
1. Podcast with dr. Manish R. Platel about the efficacy and safety of entrectinib in NTRK fusion-positive
gastrointestinal cancers
2. Video-interview with Saskia Hofstede about a new treatment option for adult patients with metastatic
colorectal cancer
3. Also older patients with previously untreated unresectable hepatocellular carcinoma derive more clinical
benefit from atezolizumab-bevacizumab compared to sorafenib
4. Capecitabine-irinotecan (CAPIRI) not superior to irinotecan monotherapy as second-line treatment for
patients with advanced gall bladder cancers
5. Trastuzumab deruxtecan effective in patients with HER2-positive advanced gastric or gastroesophageal
junction adenocarcinoma
6. Perioperative systemic therapy: feasible, safe and tolerable in patients with isolated colorectal
peritoneal metastases
